updat model reflect manag
commentari earlier month investor confer recal
januari re-affirmed respect guidanc rang
note comfort mid-point
top-lin organ growth rang vs higher-end previous
manag attribut chang cvg cardiac vascular
group franchis face headwind lvad left
ventricular assist devic dcb drug coat balloon
manag expect cvg growth come
organ vs prior guidanc /-
vs prior guidanc /- believ strength
rtg restor therapi group mitg minim
invas therapi group help off-set weaker cvg growth
separ said expect adj ep growth
compani goal plan period due
anticip step tax rate fx said base
propos tax regul expect underli tax rate
step underli level wed
note mdt tax rate guidanc
includ one-tim benefit
lower sale estim
organ maintain adj ep estim
report lower sale estim
report adj ep estim
report maintain price target
base cy ep estim
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort reflect combin follow
acquisit cov
compani data secur llc estim reuter
price target nc
price target assum cy cash ep estim risk includ
weak key end market greater share loss model delay product launch
believ deliv averag organ growth due lull major new product launch
combin competitor headwind
found minneapolis-bas lead global medic technolog compani
focus provid therapi chronic diseas compani four primari busi cardiac
vascular restor therapi minim invas therapi diabet revenu
plc incom statementin million except per share datafisc year end etot net currenc y-i expensesresearch oper incomenet interest expens amort incom tax incom adj continu year-to-year incom year-to-year incom dilut share year-to-year compani report secur llc estim plc
